Table 8.
Organ | Study (years) | Reference | Subjects | Design | Findings |
---|---|---|---|---|---|
Lynch syndrome (LS) | |||||
Endometrial and ovarian | Dove-Edwin et al. (2002) | (56) | 292 Women from hereditary nonpolyposis colorectal cancer (HNPCC) or HNPCC-like families. | Observational: all offered transvaginal ultrasounds. | Two cases of endometrial cancer (EC) presented with symptoms, neither detected by ultrasound. |
Rijcken et al. (2003) | (348) | 41 Women with MMR mutations or fulfilled Amsterdam I criteria followed for median of 5 years. | Observational: all offered annual pelvic exam, transvaginal ultrasound, CA-125. | 17 Of 179 ultrasounds gave reason for endometrial sampling with 3 premalignant lesions noted; one interval endometrial cancer presented symptomatically. | |
Renkonen-Sinisalo et al. (2007) | (57) | 175 Women with MMR mutations. | Observational: all offered transvaginal ultrasound and endometrial biopsy. | 14 cases of EC; 11 diagnosed by surveillance. Biopsy diagnosed 8 of 11 EC and 14 cases of premalignant hyperplasia. Ultrasound indicated 4 EC cases but missed 6 others. 4 case of ovarian cancer, none found by ultrasound. |
|
Lecuru et al. (2008) | (349) | 62 Women (13 with MMR mutation, 49 met Amsterdam II criteria). | Observational: annual hysteroscopy and endometrial biopsy. | 3 Malignancies in 3 patients with abnormal bleeding; 3 cases of hyperplasia in asymptomatic patients; hysteroscopy 100% sensitive for cancer or hyperplasia. | |
Gerritzen et al. (2009) | (350) | 100 Women from families with MMR mutation. | Observational: annual transvaginal ultrasound, CA-125, endometrial sampling. | 3 Atypical hyperplasias and 1 endometrial cancer diagnosed. One stage III ovarian cancer developed despite ultrasound. | |
Stuckless et al. (2013) | (351) | 174 Women with MSH2 gene mutation. | Case–control: Cases:54 patient with at least one screening exam (transvaginal, endometrial biopsy, or CA-125 test); Controls: matched women without screening. | Stage I/II cancer diagnosed in 92% of screened patients compared with 71% in control group (P=0.17). Two of three deaths in the screened group from ovarian cancer. |
|
Stuckless et al. (2012) | (46) | 322 MSH2 mutation carriers. | Observational: cancer incidence and survival in 152 screened vs. 170 not screened by colonoscopy. | Median age to CRC later in screened vs. nonscreened. Survival statistically improved in screened vs. nonscreened. |
|
Schmeler et al. (2006) | (58) | 315 Women with MMR mutation with and without gynecological surgery. | Retrospective: risk of uterine and ovarian cancer in patients with and without prophylactic/clinically indicated gynecological surgery. | No uterine or ovarian cancer in surgery group vs. 33 and 5% cancer respectively in nonsurgery group. | |
Gastric | Renkonen-Sinisalo et al. (2002) | (352) | 73 Patients with MMR mutation; 32 MMR mutation-negative family members. | Observational: Upper endoscopy with gastric biopsies. | In MMR gene-positive patients, H. pylori in 26%, atrophy 14%, intestinal metaplasia 14%. No statistical difference between gene-positive and -negative groups. |
Small bowel | Saurin et al. (2010) | (66) | 35 Patients with MMR mutations. | Observational: Capsule endoscopy and computed tomographic (CT) enteroclysis screening of small bowel. | Small bowel neoplasms were found in 8.6% of cases (1 patient with jejunal carcinoma and 2 with jejunal adenoma). Capsule endoscopy found all lesions; CT enteroscopy found cancer but missed adenomas. |
Urinary tract | Myrhoj et al. (2008) | (68) | 977 At-risk individuals in families suspected to have HNPCC/LS. | Observational: Retrospective review of screening urine cytology (UC) and diagnosis of urinary cancer. | 0.1% Of UC exams lead to diagnosis of urothelial tumor. 10× more UC exams lead to false-positive diagnosis. Sensitivity of UC was 29%. |
Familial adenomatous polyposis (FAP) | |||||
Duodenum | Bulow et al. (2004) | (144) | 367 FAP cases | Prospective: to describe the long-term natural history of duodenal adenomatosis in FAP and evaluate the indications for prophylactic duodenal surveillance | 65% Of cases had duodenal adenomas on their first endoscopy. The cumulative incidence of duodenal carcinoma was 4.5% at 57 years; cases with Spigelman stage IV adenomatosis on initial endoscopy were at higher risk compared with those with stages 0–III |
Biasco et al. (2006) | (353) | 50 FAP cases | Prospective: to evaluate the presence and severity of precancerous duodenal mucosal lesions | 86% Of cases had duodenal lesions at the end of the study compared with 38% at first endoscopy. Eleven subjects developed stage IV disease and had endoscopic or surgical resection. | |
Thyroid | Jarrar et al. (2011) | (354) | 192 FAP cases | Prospective: to clarify the incidence of thyroid cancer in patients with FAP | 38% Of cases had thyroid nodules and 2.6% had thyroid cancer. Clinical history and neck examination did not detect any of the cancers |
Peutz–Jeghers syndrome (PJS) | |||||
Gastrointestinal (GI) tract | Latchford et al. (2011) | (355) | 63 PJS cases from 48 pedigrees | Retrospective review: to assess outcomes from GI surveillance in patients with PJS | Baseline investigations were done in 12 subjects. The rest of the patients were followed for a median of 10 years and 776 procedures were performed. Of the 2,461 polypectomies done, 6 polyps contained atypia or dysplasia; there were two cases of perforation following resection of polyps >2 cm. No luminal GI cancers were diagnosed. |
Small bowel | Brown et al. (2006) | (356) | 19 Adult PJS cases | Prospective: to evaluate the performance of capsule endoscopy in small bowel surveillance of adults with PJS vs. barium follow-through | Capsule endoscopy detected more significant polyps than barium follow-through but seemed less reliable for accurately sizing 1–2 cm polyps. |
Gupta et al. (2010) | (357) | 19 Adult PJS cases | Prospective: to assess the utility of magnetic resonance (MR) enterography compared with capsule endoscopy for small bowel polyp detection in PJS | All cases underwent both procedures. MR enterography detected large polyps (>15 mm) missed in three patients by capsule endoscopy. Size assessments of large polyps appeared more reproducible with MR enterography. | |
Pancreas | Poley et al. (2009) | (358) | 44 Individuals at high risk of developing pancreatic cancer (2 PJS cases) | Prospective: to investigate the use of endoscopic ultrasound for screening individuals at high risk of developing pancreatic cancer | Initial screening detected an asymptomatic mass lesion in 3 cases (6.8%) and premalignant intraductal papillary mucinous neoplasm (IPMN)-like lesions in 16%. |
Cowden syndrome | |||||
Thyroid | Milas et al. (2012) | (345) | 225 PTEN mutative-positive cases | Retrospective: to characterize Cowden syndrome-associated malignant and benign thyroid disease | 32 Cases (14%) had thyroid cancer (mostly papillary type) at a median age of 35 years. Initial thyroid ultrasound in 16 of 25 subjects revealed thyroiditis/goiters in all >13 years of age. |